Morepen Laboratories files FY26 BRSR report, details sustainability metrics
- Morepen Laboratories filed its FY26 BRSR report, disclosing a turnover of ₹16,766.7 crore
- Capital expenditure on environmental technologies rose to 9.39% from 0% in FY25
- Energy intensity improved to 272.43 GJ per crore INR of turnover
- Scope 1 emissions decreased to 4,977.55 metric tonnes CO2 equivalent
- Workforce includes 1,314 permanent employees and 1,755 workers

*this image is generated using AI for illustrative purposes only.
Morepen Laboratories has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The filing outlines the company’s environmental, social, and governance performance across its pharmaceutical and medical device operations.
The company reported a turnover of ₹16,766.7 crore and a net worth of ₹12,454.1 crore for FY26. Exports contributed 40% of total turnover, with the business serving over 80 countries. The API segment accounted for 56.33% of turnover, while medical devices contributed 35.60%.
Environmental Performance
Morepen allocated 9.39% of its capital expenditure to technologies improving environmental and social impacts in FY26, up from 0% in FY25. Key initiatives included transitioning boiler fuel to biomass at its Baddi facility and converting boilers to dual-fuel LPG systems at Parwanoo.
Total energy consumption rose to 456,771.57 GJ from 437,741.34 GJ in the prior year. However, energy intensity improved to 272.43 GJ per crore INR of turnover, down from 282.97 GJ. Scope 1 greenhouse gas emissions fell to 4,977.55 metric tonnes from 5,941.30 metric tonnes, while Scope 2 emissions increased to 22,950.33 metric tonnes.
Social Metrics
The workforce comprised 1,314 permanent employees and 1,755 workers as of March 31, 2026. Women constituted 9.59% of permanent employees and 12.76% of workers. The company reported zero fatalities and zero lost-time injuries among employees, with a Lost Time Injury Frequency Rate (LTIFR) of 0.24 for workers.
What the Numbers Show
Capital expenditure directed toward environmental improvements surged to 9.39% of total capex in FY26, marking a significant shift from zero such spending in FY25. This investment coincided with a reduction in energy intensity per rupee of turnover, suggesting that recent green technology upgrades are enhancing operational efficiency despite higher absolute energy consumption.
Historical Stock Returns for Morepen Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +6.91% | +18.01% | +94.27% | +153.74% | +131.05% | +116.00% |
How will the significant increase in environmental capex impact Morepen's short-term profit margins versus long-term operational cost savings?
What specific regulatory or market pressures in key export destinations are driving the 40% export contribution, and how vulnerable is this segment to trade policy shifts?
Given the rise in Scope 2 emissions despite improved energy intensity, what strategies is Morepen employing to decarbonize its electricity supply?


































